Equine Multinodular Pulmonary Fibrosis in association with asinine herpesvirus type 5 and equine herpesvirus type 5: a case report by Helena Back et al.
Back et al. Acta Veterinaria Scandinavica 2012, 54:57
http://www.actavetscand.com/content/54/1/57CASE REPORT Open AccessEquine Multinodular Pulmonary Fibrosis in
association with asinine herpesvirus type 5 and
equine herpesvirus type 5: a case report
Helena Back1*, Anna Kendall2, Rodrigo Grandón3, Karin Ullman1, Louise Treiberg-Berndtsson1, Karl Ståhl1
and John Pringle4Abstract
A standardbred gelding with a history of 10 days pyrexia and lethargy was referred to the Equine Hospital at the
Swedish University of Agricultural Sciences in Uppsala, Sweden.
The horse had tachypnea with increased respiratory effort and was in thin body condition. Laboratory findings
included leukocytosis, hyperfibrinogenemia and hypoxemia. Thoracic radiographs showed signs of pneumonia
with a multifocal nodular pattern, which in combination with lung biopsy findings indicated Equine Multinodular
Pulmonary Fibrosis (EMPF). EMPF is a recently described disease in adult horses with clinical signs of fever, weight
loss and respiratory problems. The pathological findings include loss of functional pulmonary parenchyma due to
extensive nodular interstitial fibrosis which has been related to infection with the equine herpesvirus type 5 (EHV-5).
In this case, lung biopsy and tracheal wash samples tested positive for both asinine herpesvirus type 5 (AHV-5)
and EHV-5 using PCR assays. The horse failed to respond to treatment and was euthanized for humane reasons.
Postmortem examination confirmed the diagnosis of EMPF. This case suggests that not only EHV-5 alone should
be considered in association with the development of this disease.
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Equine herpesvirus type 5 (EHV-5) is one of the nine
herpesviruses known to infect Equidae [1]. The family
Herpesviridae is divided into three subfamilies: Alpha-
herpesvirinae, Betaherpesvirinae and Gammaherpesviri-
nae, where EHV-5 together with EHV-2 and EHV-7
(also called asinine herpes virus −2 [1]) are classified as
equine gammaherpesviruses [2]. EHV-5 was first isolated
in the seventies from two horses in quarantine in Aus-
tralia with clinical signs of upper respiratory tract disease
[3]. EHV-5 is recognized as a widespread finding in both
nasal secretions and peripheral blood mononuclear cells
of asymptomatic horses [4-7]. However, little is known
about the potential role of EHV-5 causing clinically or
subclinical infections associated with disease or poor
performance in horses. One study has shown a higher* Correspondence: helena.back@sva.se
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reproduction in any medium, provided the orprevalence of EHV-5 (as well as EHV-2) in horses with
airway inflammation when compared to clinical healthy
horses [8]. The asinine herpesviruses (AHV) 4 and 5 are
also classified as gammaherpesviruses and are closely
related to the equine gammaherpesviruses [9]. In horses
AHV infection has only been described sporadically.
Nonetheless, in a case–control study of horses with
respiratory disorders or “poor performance syndrome”
Fortier et al. [10] detected AHV-5 only in the clinical
case group, which suggested that AHV-5 may play a
clinically important role in horses.
There is also increasing evidence that EHV-5 may be
associated with the occurrence of Equine Multinodular
Pulmonary Fibrosis (EMPF), which was first described
in 2007 as a disease in adult horses characterized by
chronic, multifocal, fibrotic lung disease [11]. The clin-
ical presentation of EMPF includes pyrexia, weight loss
and respiratory signs ranging from mild tachypnea to
marked dyspnea. Thoracic radiographs reveal an interstitial-
to-nodular pulmonary pattern [12] and the most consistentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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genemia [13]. Histological examination of lung tissue
include multiple, well-demarcated nodular regions of
pulmonary interstitial fibrosis with mixed inflammatory
cell infiltration. Although the role of EHV-5 in EMPF
is not fully determined, there is a strong circumstantial
association of this virus with the pulmonary pathology
presented in EMPF [11]. Similarly it appears that the
gammaherpesvirus Murine herpesvirus 68 (MHV68) may
be a co-factor for the development of a comparable pres-
entation of pulmonary fibrosis seen in mice [14].
EMPF and infection with EHV-5 has been reported in
both the USA [11,12,15] and Europe [16-18]. Some of
the horses diagnosed with EMPF appeared to be infected
with both EHV-5 and EHV-2 but co-infection with
EHV-2 has not been further investigated [11,16,17]. By
comparison, AHV-4 and AHV-5 in association with
EMPF have only been described by Kleiboeker et al.
where a group of donkeys with respiratory disease at nec-
ropsy demonstrated changes associated with interstitial
pneumonia [9]. The present case report describes a stand-
ardbred gelding with clinical signs and lung pathology
consistent with EMPF. What is striking in this case is the
apparent co-infection with AHV-5 and EHV- 5. Both
viruses were detected by PCR in samples from lung tissue
and tracheal wash. While detection of AHV-5 in this
horse with EMPF does not imply causation, its role as a
pathogen in horses warrants further study, in particular
as a co-factor with EHV-5 in the development of EMPF.
Case presentation
A 4-year-old standardbred gelding weighing approxi-
mately 560 kg, was referred to the Equine Hospital at
the Swedish University of Agricultural Sciences in Upp-
sala. Prior to presentation there was a 10-day history of
fever (38.5-40°C), unwillingness to move, intermittent
tachypnea and mild cough. No nasal discharge had been
noted. The horse had been treated with procaine penicil-
lin intramuscularly and acetylcysteine orally with no
improvement. The gelding had been with the current
owner at the same farm for three years prior to presen-
tation. There was no history of contact with donkeys.
The owner has given consent for publication of this clin-
ical case.
Physical examination and laboratory findings
On admission the horse was lethargic and tachypneic
with shallow breathing. Clinical examination revealed a
rectal temperature of 38.2°C, a heart rate of 48 beats per
minute and a respiratory rate of 52 breaths per minute.
The horse was in thin body condition and increased
breathing sounds were present bilaterally over the thorax.
Further diagnostic evaluation included venous and arterial
blood sampling, endoscopy, chest radiography, ultrasoundand finally percutaneous lung biopsy. On endoscopy there
were multiple petechial hemorrhages generally distributed
on the laryngeal mucosa and a mild accumulation of
mucus in the trachea. A tracheal aspirate obtained via
the endoscope was negative for bacterial growth under
aerobic and anaerobic conditions. No cytology was per-
formed on the tracheal aspirate.
Hematological and biochemical findings included:
leukocytosis (17.7 x 109/L reference range 5.5-12), with a
mature neutrophilia (10.8 x 109/L reference range 2–
6.6), hyperfibrinogenemia (7.4 g/L reference range 1.8-
4.2) and low serum creatinine (52 μmol/L reference
range 88–145).
These findings suggested a systemic inflammatory
process. The hypocreatinemia was likely related to the
thin body condition and low muscle mass of the horse.
The arterial blood sample showed hypoxemia (Pao2
51.75 mmHg, A-a gradient 42).
Thoracic radiographs showed a generalized mixed
interstitial and nodular pattern in the lung parenchyma,
and ultrasonographic examination revealed a diffuse
roughening of the pleural surface, without signs of free
fluid in the thorax.
A transthoracic lung biopsy was performed, under
ultrasound-guidance, using a BARD Magnuma on the
right side of thorax following sedation with butorphanol
(ButadorW)b and detomidine i.v. (CepesedanW)c and local
anesthesia of the skin and deeper tissues at the biopsy
site. Histological examination of the lung biopsy per-
formed with hematoxylin and eosin (HE) staining
demonstrated fibrosis with a widening of the interstitial
space and presence of mature, intermittently hyalinated
collagen. In the same area a mild to moderate infiltrate
of inflammatory cells (mainly lymphocytes, a few macro-
phages and neutrophilic granulocytes) was present.
Fibrosis was seen around smaller bronchioles and
cuboidal cells lined alveoli. The epithelium of the
bronchioles was intact and showed mild to moderate
exocytosis. In alveoli and in some bronchioles a moder-
ate to marked infiltrate of inflammatory cells mostly
composed of degenerated neutrophils was observed.
A histological diagnosis of chronic active interstitial
fibrotic pneumonia was made.
No fungi were detected with periodic acid-shiff (PAS)
staining and there was no bacterial growth obtained from
culture of the biopsy under aerobic or anaerobic conditions.
According to a multi PCR analysis for respiratory
viruses in horsesd, a sample from nasal swab was nega-
tive for Equine Influenza Virus, EHV-1, EHV-4, Equine
Rhinitis B Virus and Equine Arteritis Virus.
Treatment and outcome
Initially the horse was treated with salbutamol (Ven-
tolineW)e 0. 7 mg/kg administrated via Aeromaskf, and
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(DexadresonW)g 0. 1 mg/kg bwt i.v. q 24 h and penicillin
(GeepenilW)h 27 167 IU/kg bwt i.v. q 8 h.
The horse did not respond to treatment and 3 days
after admission started showing signs of severe dyspnea.
Due to the clinical deterioration and the poor prognosis,
the horse was humanely euthanized.
Postmortem examination
At necropsy, multifocal to coalescing pale, firm, well-
demarcated nodules varying in size from 2–10 cm were
detected affecting all lung lobes (Figure 1) and only very
small areas of normal parenchyma were visible. Further,
the tracheobronchial lymph nodes were markedly
enlarged; reaching approximately 8 x 3 cm.
Histological examination (Figure 2) of the lung tissue
with hematoxylin-eosin (HE) and Masson´s trichrome
stained sections demonstrated a moderate to severe,
multifocal to coalescing interstitial fibrosis with presence
of mature collagen. In the interstitial area mild to mod-
erate infiltrates of inflammatory cells composed of lym-
phocytes, macrophages and neutrophils were observed
whereas the airspace of the affected alveoli was lined
by cuboidal epithelial cells (type II pneumocytes). The
epithelium of bronchioles showed hypertrophy. Marked
infiltrates of inflammatory cells, mostly composed of
degenerated neutrophils, were detected in alveolar
spaces and in some bronchioles.
PCR and sequence analysis
The clinical signs, findings at necropsy and absence of
other pathogens corresponded well with EMPF, and thus
samples from lung tissue and tracheal wash were sub-
mitted for further virus examination. A broadly reacting
nested consensus primer PCR, designed for detection ofFigure 1 The photo shows lung from the affected gelding.
Fibrotic nodules are large, whitish, and multifocal to
coalescing. There are sharp borders between nodules and adjacent
normal lung tissue.a wide variety of herpesviral genomes and targeting
215–315 base pair segment of the DNA polymerase was
performed on DNA extract from samples of lung tissue
and tracheal wash [19,20]. Viral nucleic acid was
extracted using a magnetic bead separation method and
subsequently amplified with the consensus primer PCR.
Second round amplification products were separated in
agarose gel with ethidium bromide and visualized under
ultraviolet light. Bands with the approximate size of 200
base pairs were visible on the gel indicating the presence
of herpesvirus. For sequence analysis the PCR products
from the second round were reamplified and sequenced
as previously described [19]. The 195 nt sequence
obtained showed 98-100% nucleotide identity when
compared with AHV-5 sequences available in GenBank
using the blastn tool (http://www.ncbi.nlm.nih.gov/blast/
Blast.cgi), and between 85–97% nucleotide identity with
other available equine herpesviruses originating from do-
mestic or wild equids. In order to gain more sequence
information a primer pair designed for gammaherpes-
virus also targeting the DNA polymerase gene and in-
cluding the fragment produced by the consensus PCR
was applied to the extracted DNA [21]. The PCR pro-
ducts were sequenced in both directions with the same
primers. When comparing the sequence data, this new
PCR product of 847 nt was found to be 99% identical to
EHV-5 (GQ325597) whereas the part overlapping the
consensus PCR fragment was only 87% identical to the
previously obtained sequence. The results were con-
firmed by repeated PCR amplification and sequencing.
Phylogenetic analysis was performed on the overlapping
fragments of AHV-5 and EHV-5 and related equine
herpesviruses sequences obtained from GenBank (virus/
accession number: EHV-2/HQ247790, EHV-5/GQ325597,
EHV-7/EU165547, AHV-5/FJ798319, Zebra Herpesvirus/
AF141889, Wild Ass Herpesvirus (WAHV)/AF141888,
and Eastern Kiang herpesvirus/EU717156 incorrectly
denominated EHV-9 in GenBank) using Neighbour-
joining and the Kimura-two-parameter model as imple-
mented in SplitTree4 [22] clearly confirming the close
relation between the sequences obtained with AHV-5
and EHV-5, respectively (Figure 3).
Conclusions
This case report describes a horse with clinical signs
and histological changes within the lung that corres-
pond with the recently described disease EMPF [11]
that has been associated with infection by EHV-5. What
was noteworthy in this clinical case was that AHV-5
was also found along with EHV-5, making it unclear
whether one, or both in concert were responsible for
the pulmonary disease.
AHV-5 and EHV-5 are two separate viruses. As can be
shown in the phylogenetic tree (Figure 3) there is a close
Figure 2 a) Lung of the horse showing interstitial fibrosis (blue) around the alveoli. Masson trichrome staining. b) Alveolus lined by
cuboidal epithelial cells (type II pneumocytes) and surrounded by a fibrous stroma. The alveolar space filled by numerous inflammatory cells,
primarily neutrophils. Hematoxylin and eosin staining.
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present case with reference sequences for AHV-5 and
the WAHV. Albeit based on short fragment of the gen-
ome the phylogeny show a distinct difference between
AHV-5 and EHV-5 even though they both belong to the
gammaherpesvirus subfamily.
Pulmonary interstitial fibrosis is an uncommon disease
in horses and has often been described as being idio-
pathic in origin [23,24]. In human medicine consider-
ably more research has been conducted on the genesis
of idiopathic pulmonary fibrosis (IPF) but the patho-
genesis remains unclear. IPF may be related to epithelial
cell injury, abnormal fibroproliferation, inflammation and
deposition of extracellular matrix components. Several
viruses, especially gammaherpesviruses, have been impli-
cated as co-factors for initiating, promoting or exacerbat-
ing IPF [14,25-27]. While these studies do not proveFigure 3 Unrooted phylogram based on a 166 nucleotide fragment o
sequences together with selected related equine herpesvirus sequen
EHV-5/GQ325597, EHV-7/EU165547, AHV-5/FJ98319, Zebra Herpesviru
Kiang Herpesvirus/EU17156 incorrectly denominated EHV-9 in GenBa
Kimura-two-parameter model in SplitsTree4. Numbers indicate the boo
shown in the figure. Branch distances are proportional to sequence distanc
obtained in this study (marked with blue circles) and preciously describedtotal causality, the association between gammaherpes-
viruses and IPF like conditions in horses, mice and
human is striking.
To the authors´ knowledge, this is the first report of
EMPF in Sweden and also the first report with AHV-5
in horses in association with EMPF. Previous studies
on EMPF appear to have focused their investigations
on EHV-1, EHV- 2, EHV-4 and EHV-5 thus the co-
presence of the AHV in some of those cases may also
have occurred. However, even if this report indicates an
association, further studies with inclusion of age and
breed-matched control horses are needed to define the
possible role of AHV-5 in the pathogenesis in EMPF and
a baseline prevalence study could give valuable infor-
mation about the distribution and importance of this
pathogen. Furthermore, the development of a quantitative
PCR for EHV-5 and AHV-5 would be of benefit tof the DNA polymerase gene from obtained AHV-5 and EHV-5
ce from GenBank (virus/accession numbers: EHV-2/HQ247790,
s/AF141889, Wild Ass Herpesvirus (WAHV)/AF14188, and Eastern
nk), constructed using the Neighbor-joining method and the
tstrap values (1000 replicates) and only the values above 70% are
es. The figure indicates a strong relationship between the sequences
representatives of EHV-5 and AHV-5, respectively.
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tity at the site of the lesions, possibly indicating an active
role in the pathogenesis.
In conclusion, it appears that not only EHV-5 but also
other equine gammaherpesviruses should be considered
when investigating the cause/s of EMPF.
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